Thrombelastography detects the anticoagulant effect of rivaroxaban in patients with stroke.
about
Allosterism-based simultaneous, dual anticoagulant and antiplatelet action: allosteric inhibitor targeting the glycoprotein Ibα-binding and heparin-binding site of thrombin.In vitro reversal of supratherapeutic rivaroxaban levels with coagulation factor concentratesEmergency reversal of anticoagulation: novel agents.Global assays of hemostasis.Reversal of anticoagulant effects in patients with intracerebral hemorrhage.Non-Vitamin K Oral Anticoagulants (NOACs) and Their Reversal.
P2860
Thrombelastography detects the anticoagulant effect of rivaroxaban in patients with stroke.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Thrombelastography detects the ...... xaban in patients with stroke.
@en
Thrombelastography detects the ...... xaban in patients with stroke.
@nl
type
label
Thrombelastography detects the ...... xaban in patients with stroke.
@en
Thrombelastography detects the ...... xaban in patients with stroke.
@nl
prefLabel
Thrombelastography detects the ...... xaban in patients with stroke.
@en
Thrombelastography detects the ...... xaban in patients with stroke.
@nl
P2093
P2860
P1433
P1476
Thrombelastography detects the ...... xaban in patients with stroke.
@en
P2093
James C Grotta
Joancy M Archeval-Lao
Mohammad H Rahbar
Ritvij Bowry
Stephanie A Parker
Stuart Fraser
P2860
P304
P356
10.1161/STROKEAHA.113.004016
P407
P50
P577
2014-01-14T00:00:00Z